Volume 88 Issue 36 | pp. 32-33
Issue Date: September 6, 2010

Policing The Pharma Supply Chain

Drugmakers and regulators are struggling to secure a market that relies heavily on outsourcing
Department: Business | Collection: Economy
Keywords: active pharmaceutical ingredients, outsourcing, FDA, supply chain management

Two years after adulterated heparin produced in China killed 81 people in the U.S., Western drug companies, their ingredient suppliers, and regulatory agencies are aligning efforts against unsafe imports. Sources in all quarters agree that the heparin case heightened public awareness of a safety threat and provided a wake-up call to drugmakers, the U.S. Food & Drug Administration, and other regulators. But guarding the global pharmaceutical supply chain against contaminated or unsafe ingredients . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society